Home
Thomas Andrew Crockett, CEO: KalVista Pharmaceuticals KALV Sell · Filed 23/12/28
Trade details
- Type
- Insider sale
- Amount
- $360,600
- Shares · price
- 30,000 sh · $12.02 a share
- Held after
- 127,532 sh
- Trade date
- 23/12/27
- Filed
- 23/12/28
- Days to filing
- 1 days
Sold 19.0% of holdings
- Share of holding sold
- 19.0%
KalVista Pharmaceuticals trades, last 26 weeks
What else happened in KalVista Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 23/11/27~24/01/26Thomas Andrew Crockett's recent trades
- Thomas Andrew Crockett
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$351.2K
24,888 sh
$351.2K
Filed 24/02/21
Traded 24/02/20
- Thomas Andrew Crockett
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$875.9K
58,356 sh
$875.9K
Filed 24/02/16
Traded 24/02/14
- Thomas Andrew Crockett
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$150.5K
9,300 sh
$150.5K
Filed 24/02/05
Traded 24/02/01
- Thomas Andrew Crockett
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$11.8K
700 sh
$11.8K
Filed 24/02/05
Traded 24/02/01
- Thomas Andrew Crockett
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$121.9K
14,807 sh
$121.9K
Filed 23/11/21
Traded 23/11/20